Markets have staged a powerful relief rally on June 15 as expectation of a possible US-Iran peace deal eased fears of an oil shock and reduced one of the biggest risks hanging over the global economy. For India, lower crude prices could mean everything from a stronger rupee and lower inflation to improved corporate margins and a better earnings outlook. Yet, investors know that relief rallies are easy. Sustaining them is much harder. Valuations are not cheap, global capital continues to chase the AI trade, earnings growth still needs to accelerate, and the path of interest rates remains uncertain. The next leg of the market will depend less on headlines and more on whether the fundamentals begin to improve.
Moneycontrol of Network18 brings together some of the biggest market voices, hard data and diverse perspectives to answer the questions that matter most for investors in today's exclusive coverage...... . VALI disclosures . .....
"Value Appraisal and Leveraged Investing"
Pages
- Home
- HOLDINGS:
- *****
- BANK BEES
- GOLDBEES
- SILVER BEES
- NOTES
- TECHNICAL GUIDE (click here)
- Abbreviations for Commerce
- IT
- Disclaimer: Derivatives trading must be done only by traders who fully understand the risks associated with them and strictly apply risk mechanisms like stop-losses. The information is only for consumption by the client and such material should not be redistributed. We do not recommend any particular stock, securities and strategies for trading. The securities quoted are exemplary and are not recommendatory. The stock names mentioned in this article are purely for showing how to do analysis. Take your own decision before investing.
- Foreign Direct Investment (FDI) and Foreign Portfolio Investment (FPI) are distinct forms of international investment with different characteristics and implications. FDI involves a long-term commitment with the aim of controlling or influencing the operations of a foreign business, while FPI involves investing in foreign financial assets like stocks and bonds, typically with a shorter-term focus and without gaining operational control. Here's a more detailed breakdown: Foreign Direct Investment (FDI): Long-term commitment: FDI investors typically seek a lasting presence in the foreign market, often through establishing new businesses (greenfield investment) or acquiring existing ones (brownfield investment). Control and influence: A key feature of FDI is the investor's ability to influence or control the operations of the foreign business. Resource and technology transfer: FDI often involves the transfer of resources, technology, and expertise from the investor's country to the host country, potentially boosting economic development. Potential for higher returns: While FDI involves greater risk, it also offers the potential for higher long-term returns. Foreign Portfolio Investment (FPI): Short-term focus: FPI investors typically have a shorter-term investment horizon, seeking to profit from market fluctuations and changes in asset prices. Passive investment: FPI investments are typically passive, meaning investors do not have direct control or influence over the management of the companies they invest in. Focus on financial assets: FPI involves investing in financial assets like stocks, bonds, and other securities. Liquidity and volatility: FPI can be more liquid than FDI, but it is also more susceptible to market volatility and can be easily withdrawn. In essence: FDI is like buying a business or building a factory in another country, aiming for long-term control and influence. FPI is like buying shares of a company on a stock exchange, with the goal of making a profit from price changes in the short-term.
logo
Monday, June 15, 2026
15/06/26, PostMarket REPORT
15/06/26, Morning Stock Market News
Stocks rallied, Oil slumped and the dollar fell after the US and Iran said they had reached a deal to reopen the Strait of Hormuz.
A gauge of Asian shares jumped 2.1% at the open, while S&P 500 futures were up 1%. The dollar declined against its major peers and Treasuries rose across the curve. Brent crude fell more than 4% toward $83 a barrel, after closing last week at the lowest in more than three months. Bitcoin climbed more than 2%.15/06/26, Gold Prices among peace deals
Gold rose more than 1% on Monday, after U.S. and Iran officials said they had reached a deal to end their conflict, pushing oil prices lower and easing concerns about inflation and higher interest rates.
Spot gold was up 1.8% at $4,297.42 per ounce, as of 0010 GMT, its highest level since June 9. U.S. gold futures for August delivery rose 1.9% to $4,318.10.15/06/26, Iran Vs US
The United States and Iran have reached a deal to end their war and will hold an official signing ceremony on Friday in Switzerland, Pakistani Prime Minister Shehbaz Sharif said on social media early on Monday.
US President Donald Trump announced that a peace agreement with Iran had been finalized, declaring that the strategically vital Strait of Hormuz would be reopened and that the United States would end its naval blockade in the region.Sunday, June 14, 2026
14/06/26, SpaceX Debut
SpaceX made a historic stock market debut on Friday — surging past $2 trillion on Nasdaq and elevating Elon Musk to trillionaire status. The rocket company opened around midday at $150 a share and jumped nearly 20% as trading continued. SpaceX finished the day just below $161 with a market value of $2.1 trillion
Investors have jumped at the chance to get a piece of Musk’s sprawling empire spanning rockets, satellites and AI after the record-setting $75 billion IPO. According to a Reuters report, more than 510 million shares worth about $84 billion changed hands — even though SpaceX is currently unprofitable and generated only a fraction of the revenue brought in by similarly valued tech giants.
“I gave SpaceX less than a 10% chance of succeeding at all. To be clear, in fact, I told people this. I said, look, we’re probably going to fail, but you know, should give it a try, because if we don’t, if there’s not a new company that enters space, we will never be a truly space-bearing civilization,” Musk said on Friday.
World’s first trillionaire
Elon Musk has become the first and only trillionaire in the world following the SpaceX listing on Friday. According to the Forbes realtime billionaire’s list, he is now worth $1.1 trillion after gaining $61.2 billion within a single day.
SpaceX opened around midday at $150 a share, then rose to around $168, before finishing the day just below $161. That price gave the company a market value of $2.1 trillion, making it the sixth largest public US company. The figure is even higher than electric vehicle maker Tesla where Musk is also the CEO.
The trillionaire businessman recently told JPMorgan CEO Jamie Dimon that the company was going public to fund its ambitions of putting 100,000 satellites and data centers in space and eventually establishing a colony of people on Mars. He noted that deploying AI data centers in space is a “massive new growth base and you need capital for that”.
How does the IPO impact the company?
Betting on SpaceX is in many ways a bet on Musk himself. He holds 82% interest in a special B class of shares that gives him sweeping control over the company, even though his ownership stake is about half that. The unusual arrangement has drawn criticism from shareholder watchdogs.
His shares give Musk control over decisions related to the company’s strategy, finances and personnel. It also makes things so that the only person who can fire Elon Musk as CEO…is Elon Musk. SpaceX credits him as the “driving force” behind its growth, innovation and success. The company has repeatedly warned that the loss of Musk could disrupt its ability to execute its strategy as well as hurt its “reputation and relationships with customers, partners and other stakeholders.” It also contends that finding a replacement with the same skills and experience as the trillionaire would be time-consuming, if not nearly impossible.
SpaceX excluded from S&P 500 Index
SpaceX will not enter the S&P 500 or the Dow Jones Industrial Average for several months yet. Both have opted to stick with established and more traditional thresholds that do not allow SpaceX or other companies with gargantuan IPOs faster entry. That means even high-profile companies will still need to wait for their stocks to trade a full 12 months before they can enter the index.
Companies want to be in the S&P 500 in particular because it’s arguably the most important index on Wall Street, with trillions of dollars either mimicking it exactly or benchmarked against it.
Losses and the way forward
The rocket company has made a series of lofty promises in recent years — from establishing a one-million person Martian colony to ‘saving humanity’ by establishing other outposts in space. It also plans to launch data centers the size of football fields into orbit and outdo rivals Anthropic and OpenAI in the race to make money from artificial intelligence. But its goals require a significant influx of cash — billions more than it currently takes in from its rocket and satellite business. Data shows that Space Exploration Technologies Corp. lost $8.7 billion between the start of 2025 and March 31 this year.
“Whoever you are watching this, SpaceX wants to be able to take you to the moon, take you to Mars and ultimately beyond,” Musk said while joining a ceremonial opening bell ringing from Starbase.
What are the challenges for SpaceX?
According to an AP report, Wall Street bankers that helped take SpaceX public are also enthusiastic about the company — and the big fees they will earn — but not everyone thinks the stock price is justified. Analysts at research firm Morningstar, which doesn’t earn any investment banking fees, wrote that the IPO is “significantly overvalued.”
Citing SpaceX’s technology challenges, including shielding its orbiting datacenters from radiation damage and catching up to leaders in AI such as Anthropic and OpenAI, they estimated the company is only worth $780 billion — less than half its IPO value.
SpaceX itself has hinted at the challenges, conceding in regulatory documents that some of its business plans rest on “unproven technologies.” It also indicated that another part of the company, its artificial intelligence business called xAI, has no clear path to profitability and is burning cash to catch up with rivals.
Report by Anvesha Misra,
Source:Financial Express
Friday, June 12, 2026
12/06/26, This is completely Untrue!
Iran has rejected reports that it is preparing to sign an agreement with the United States in Geneva on Sunday, pushing back against claims that negotiations have already produced a finalised deal.
According to Al Jazeera, an unnamed source close to Iran's negotiating team dismissed media reports suggesting that a signing ceremony was imminent, describing such claims as entirely false.12/06/26, Commodity News
Commodity markets traded on a mixed note on June 12 as investors weighed developments in the Middle East, movements in the US dollar, and the global demand outlook.
Crude oil prices extended losses after reports that US President Donald Trump cancelled plans for military strikes on Iran, easing concerns over a broader regional conflict. Brent crude futures fell 1.3 percent to $89.17 a barrel, while WTI crude declined 1.4 percent to $86.48. For the week, Brent and WTI were down 4.2 percent and 4.4 percent, respectively.12/06/26, PostMarket REPORT
Indian equity markets staged a sharp rebound on June 12, with the combined market capitalisation of all companies listed on the NSE surging by nearly Rs 10 lakh crore, marking the biggest single-session gain in a month. The rally mirrored gains across global markets and was supported by a sharp decline in oil prices after fresh indications that the US and Iran are nearing a provisional agreement to end their conflict.
At the close of trade, the total market capitalisation of NSE-listed companies stood at Rs 462 lakh crore, up Rs 9.66 lakh crore from Rs 452.34 lakh crore in the previous session. Benchmark indices posted strong gains, with the Sensex and Nifty rising 2.3 percent, or 1,695.4 points, to close at 75,527.95 and 23,622.90, respectively. The Nifty MidCap 100 and SmallCap 100 indices advanced 2.5 percent each.12/06/26, Market Prediction
Indian benchmark indices Sensex and Nifty are poised for a strong opening on Friday. The GIFT Nifty surged more than 250 points in early trade, tracking a sharp rally in global equities markets and a steep decline in crude oil prices amid renewed optimism over a potential peace deal in the Middle East.
GIFT Nifty was trading at 23,455 at around 8:05 am, up 255 points or 1.1 percent, indicating that the Nifty 50 could open well above Thursday's close of 23,161.60. The positive signal comes after Indian markets ended lower in a volatile session on Thursday, with the Sensex declining 151 points and the Nifty slipping below the 23,200 mark amid broad-based selling pressure.12/06/26, India’s allocation in Global Emerging Market (GEM)
In its latest report, Citi Research said India’s allocation in Global Emerging Market (GEM) funds is currently at a five-year low. The brokerage noted that India’s weight in the global emerging market index has declined from around 20% in mid-2024 to about 11%, while global portfolios remain close to a 20-year high underweight position on Indian equities.
According to Citi, foreign investor sentiment towards India remains subdued amid persistent geopolitical uncertainty and the associated macroeconomic challenges. The brokerage also highlighted concerns that India is not a significant participant in the global AI infrastructure buildout, making it important to monitor the medium- to long-term implications for employment, wages and consumption.
Valuation Revisions
It also added that while valuations have become more reasonable, with markets trading closer to their 10-year historical averages. However, it lowered its forward price-to-earnings multiple assumption for the Nifty from 19 times in December 2027 to 18 times in March 2028, resulting in a revised 12-month target of 26,000 for the index. The target is 1,000 points lower than its previous estimate of 27,000, reflecting concerns around geopolitics, AI-related developments and weather-related risks. Citi added that its Citi India Sentiment Indicator (CISI) points to potential one-year forward returns of about 10%.
Despite these concerns, Citi maintained a constructive medium-term outlook on India. It said any easing of tensions in West Asia or a pause in foreign institutional investor (FII) outflows could provide an upside trigger for markets. “Global flows may remain volatile in the near term as AI sentiments fluctuate, and some tempering in AI optimism may reduce FII outflow pressures for India,” the report said.
Commenting on fourth-quarter FY26 earnings, it noted that headline EBITDA growth for the BSE100 stood at around 6 % year-on-year, marginally below its estimates and historical trends. The brokerage identified crude oil prices and a potential El Niño event as key risks, while questioning the sustainability of strong consumer demand trends witnessed during the quarter. It added that rising input costs have prompted companies to implement price hikes.
The report highlighted several themes to monitor, including the impact of any slowdown in Global Capability Centres (GCCs) on employment and wage growth, the resilience of domestic investment flows, and the evolving AI narrative as value creation shifts from AI enablers to AI beneficiaries.
On sectors, Citi remains overweight on financials, telecommunications, healthcare, utilities and defence, while maintaining an underweight stance on IT services, consumer staples and metals.
Sector Preferences
Separately, financial services firm PL Capital cut its 12-month Nifty 50 target by 631 points to 26,449 from 27,080. The brokerage valued the index at a 10% discount to its 15-year average price-to-earnings multiple of 17.2 times in its base-case scenario. It projected a bull-case target of 29,387 and a bear-case target of 20,771.
PL Capital favours themes such as private banks, non-banking financial companies (NBFCs), metals, capital goods, defence, data centres, renewable energy, railways, ports, shipbuilding, semiconductors and healthcare. The brokerage remains cautious on IT services, consumer-facing sectors, chemicals, agriculture and oil and gas.
“While markets are unlikely to witness a significant correction below recent lows, prolonged geopolitical uncertainty could continue to drive sharp volatility,” PL Capital said.
Artical written by Kushan Shaw
Source: Financial Express
12/06/26, Two Pharma companies earn a Return On Capital Employed (ROCE) of more than 80%, which is very rare.
Asset-Light Strategies Driving Extraordinary Capital Efficiency
Most investors hunt for fast growth. Yet some of the steadiest money is made by dull businesses that need little capital, throw off a lot of cash, and hand most of it back to shareholders. Two Pharma companies fit that description almost perfectly today. Both earn a return on capital employed (ROCE) of more than 80%, which is very rare.
For context, the wider industry earns a ROCE of about 15% and pays a one-year dividend yield of roughly 0.09%. Against that, our two names look unusual. The first posts a ROCE of about 84% and a yield near 2%. The other posts a ROCE of about 90% and a yield close to 1.6%. Both beat the sector on the two numbers that matter most to a cash-focused investor.
There is a simple reason for this. Neither runs a heavy, factory-led business. They sell well-known consumer health brands, keep very little money tied up in fixed assets, and pay most of their profit out as dividends. A healthy operating profit divided by a small capital base produces a very high ROCE. That is the story in one line. The rest of this piece checks whether it holds up once you read the fine print.
#1 P&G Health: A Brand Cabinet Most Indians Already Own
P&G Health Ltd is part of the Procter & Gamble group, which holds about 52% of the company. It is one of India’s largest producers of vitamins, minerals and supplements.
With a market cap of around Rs 10,329 cr, the company makes products like Evion, Neurobion, Seven Seas, Nasivion, Polybion Livogen etc. These are old, trusted names, and that is the quiet pricing power that makes a brand business durable.
The Dividend Payout Framework: Capital Extraction Outperforming Annual Net Profit
This is where P&G Health stands apart. The company has a dividend yield of about 2%, against the industry median of just 0.09%. But the headline understates the generosity. Over the trailing twelve months the company paid Rs 205 per share, made up of a Rs 110 interim and a Rs 50 special in February 2026, plus a Rs 45 final earlier.
At the current price that is a trailing yield above 3%. Screener.in also shows a dividend payout that has run above 100% of profit in several recent years, meaning the company returns more than it earns by drawing on its cash pile. It has paid dividends for more than two decades. For an income-minded investor, that record is the main attraction.
Navigating P&G Health’s Skewed Trailing Disclosures
P&G Health has changed its financial year twice. It moved from a December close to a June close, with an 18-month stretch ending June 2020, and then to a March close, with a 9-month stub ending March 2025. That makes a clean five-year growth rate misleading, since you end up comparing periods of different lengths. So, I am showing the actual yearly figures rather than a single number that would flatter or fool.
| Financial Year | FY21 (Jun) | FY22 (Jun) | FY23 (Jun) | FY24 (Jun) | FY25* (9m) | FY26 (Mar) |
| Sales (Rs cr) | 1,009 | 1,114 | 1,230 | 1,151 | 934 | 1,408 |
| EBITDA (Rs cr) | 246 | 268 | 325 | 307 | 319 | 457 |
| Net Profit (Rs cr) | 177 | 193 | 229 | 201 | 234 | 327 |
Read across the full years and the trend is clear. Operating profit has roughly doubled, from Rs 246 cr in FY21 to Rs 457 cr in the year to March 2026, and net profit has grown from Rs 177 cr to Rs 327 cr. That is healthy, margin-led growth. Sales, though, have crawled. Screener even shows five-year sales growth of under 1%, but that figure is distorted by the 18-month year in the base.
A fair takeaway would be that profit has compounded in the low teens while the top line has been sluggish. This company grows earnings through better margins and cost control, not rapid sales gains.
The share price of Procter & Gamble Health Ltd was around Rs 5,800 in June 2021 and as of closing on 10th June 2026 it was Rs 6,224.
P&G Health Long-Term Price Chart

On valuation, the stock trades at a price-to-earnings (PE) ratio of about 32x, which is same as the current industry. A caution on the longer view: a clean ten-year median PE is hard to trust here. The same year-end changes, plus a one-off gain of about Rs 768 cr in 2018, distort the historical earnings series. I would rather flag that than hand in a tidy but unreliable number.
Asset-Light Operational Mechanics: Breaking Down P&G’s 84% ROCE
P&G Health’s ROCE for the year to March 2026 is about 84%, and its return on equity is about 62%. In plain words, for every Rs 100 of capital the company uses, it earns roughly Rs 84 of operating profit. This is while its peers from the industry average about 15%.
The company keeps little money locked up, runs on a slim asset base, and pays most of its profit out as dividends, which keeps its equity small. A small base under a solid profit produces a very large ratio. The business is a good one, but the eye-popping figure is partly an effect of how little capital it retains.
#2 Sanofi Consumer Healthcare: Two-Year-Old Company with Decades-Old Brands
Sanofi Consumer Healthcare India was incorporated only in 2023. It was carved out of Sanofi India through a demerger to create a standalone consumer health business, and listed soon after. The company is new, but the brands are not. It owns Allegra for allergy relief, Combiflam for pain, Avil, and DePURA for vitamin D. These are household names, which is the whole point of an over-the-counter consumer health business.
With a market cap of Rs 10,791 cr, the company operates across a range of channels, including distributors, wholesalers, government institutions, hospitals, pharmacies, pharmacy chains, and e-commerce platforms. It also has various independent third-party manufacturers.
One number stands out on the shareholding page. Promoter holding rose from 60% in March 2025 to over 71% in March 2026, as the Sanofi parent raised its stake. When the owner of a business buys more of it, investors usually take notice. Over the same period, foreign and domestic institutions trimmed their holdings, so the float that the public can trade has shrunk.
Asset-Light Operational Mechanics: Demystifying P&G’s 84% Return on Capital Employed
Now, the 5-year figures for the company would not be of much use, as it was formed recently and it has not existed long enough as a separate entity. However, here is the most recent full year against the one before, built from the quarterly results (Source: Screener.in).
| Period | FY25 (Apr 24 to Mar 25) | FY26 (Apr 25 to Mar 26) | % Growth |
| Sales (Rs cr) | 676 | 935 | 38% |
| EBITDA (Rs cr) | 253 | 334 | 32% |
| Net Profit (Rs cr) | 168 | 258 | 54% |
These are full years built from quarterly filings. Operating margin has held in a strong 35% to 39% band. This is fast growth, and the December 2025 quarter was strong, with sales up about 47% and net profit up about 50% over the year before. But the base is short and shaped by the demerger, so we would treat one or two years as a starting point, not proof of a long trend.
The share price of Sonafi Consumer was about Rs 4,900 when listed in September 2024 and as of closing on 10th June 2026 it was Rs 4,675 which is a considerable drop. The stock is currently trading at a discount of about 22% from its all-time high of Rs 5,954.

Sanofi Consumer Healthcare Long-Term Price Chart
On valuation, the stock trades at a PE of 43x against the current Industry median of 32x, hence trading at a small premium to the sector’s median.
The risks are the short trading history, the thin float after the promoter buying, the steep multiple on book value, and the auditor change. The pull is a portfolio of strong brands, almost no debt, the highest ROCE in the pair, and a rising dividend.
Valuation Premiums vs. Capital Yields: Sanofi’s 90% ROCE Against Its Trading History
Sanofi Consumer is the more extreme of the two on returns. Its ROCE is about 90% and its return on equity about 72%. So, for every Rs 100 of capital employed, it produces about Rs 90 of operating profit, while industry peers average about 15%. As with P&G Health, that is partly a sign of how little capital the business needs, not just how well it runs, and the short history gives the ratio less to stand on.
Regarding dividends, Sanofi Consumer yields about 1.6%, which still beats the sector. It paid a Rs 55 final dividend in April 2025, and the board has recommended a much larger Rs 75 per share final dividend, with a record date in June 2026. That is a clear step up.
One item deserves a plain mention. The company’s auditor, Kalyaniwalla & Mistry LLP, resigned at the end of April 2026 over what was described as a fee dispute, and PwC was appointed in its place in May. An auditor change is not, by itself, a red flag, and the stated reason was fees. But any auditor change at a newly listed company is worth watching, and I would rather point it out than skip past it.
Balancing Consistent Dividend Inflows Against Growth Frontiers
Both companies are real cash machines and they own brands people buy without thinking, carry almost no debt, earn far more on their capital than the sector does, and pay out more in dividends than most peers. For an investor who wants steady income and quality, that is a rare and appealing mix.
But the same features that make the ROCE look stunning also set the limits. These businesses are high return precisely because they keep so little capital and pay so much out, which leaves less to reinvest for growth. P&G Health has grown profit nicely, yet its stock has been flat for five years, a reminder that the price you pay matters as much as quality. Sanofi Consumer is growing faster, but it is young, lightly traded, and has just changed its auditor. Neither is a bargain on book value.
However, these are not get-rich-quick stories. They are slow, cash-rich, dividend-led businesses where the main risk is overpaying for the comfort they offer. For a watchlist For a watch list built on quality and income, both earn a place. Whether today’s price is the right entry is the question each reader will have to answer.
Article written by Suhel Khan
Source: FinancialExpress
Disclaimer:
Note: We have relied on data from http://www.Screener.in and http://www.trendlyne.com throughout this article. Only in cases where the data was not available, have we used an alternate, but widely used and accepted source of information.
The purpose of this article is only to share interesting charts, data points and thought-provoking opinions. It is NOT a recommendation. If you wish to consider an investment, you are strongly advised to consult your advisor. This article is strictly for educative purposes only.
Suhel Khan has been a passionate follower of the markets for over a decade. During this period, he was an integral part of a leading Equity Research organisation based in Mumbai as the Head of Sales & Marketing. Presently, he is spending most of his time dissecting the investments and strategies of the Super Investors of India.
Disclosure: The writer and his dependents do not hold the stocks discussed in this article. The website managers, its employee(s), and contributors/writers/authors of articles have or may have an outstanding buy or sell position or holding in the securities, options on securities or other related investments of issuers and/or companies discussed therein.
12/06/26, Trump's Announcement of The Day
US President Donald Trump on Thursday announced that he had cancelled planned military strikes against Iran, claiming that discussions with Tehran had reached the highest levels of the Iranian leadership and that the broad framework of a deal had been approved by all parties involved.
In a post on Truth Social, Trump said he had called off airstrikes that were scheduled for later in the day after receiving indications that negotiations were moving toward a final agreement.Today's
15/06/26, PostMarket REPORT
Markets have staged a powerful relief rally on June 15 as expectation of a possible US-Iran peace deal eased fears of an oil shock and reduc...
-
Renewable energy is no longer a distant theme. It has become central to how countries think about power , industry and energy secu...
-
OPM% almost always refers to Operating Profit Margin , a core financial metric that indicates how much profit a company makes from its co...
















